Wormser Freres Gestion’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$671K Sell
560
-94
-14% -$96K 0.38% 24
2026
Q1
$615K Sell
654
-23
-3% -$23.3K 0.44% 21
2025
Q4
$728K Buy
677
+191
+39% +$183K 0.41% 24
2025
Q3
$371K Buy
486
+5
+1% +$3.72K 0.21% 30
2025
Q2
$375K Buy
481
+10
+2% +$7.77K 0.22% 29
2025
Q1
$389K Buy
471
+138
+41% +$115K 0.24% 30
2024
Q4
$259K Buy
333
+197
+145% +$163K 0.15% 30
2024
Q3
$121K Hold
136
0.07% 34
2024
Q2
$127K Buy
+136
New +$109K 0.08% 34

Other funds holding LLY

Wormser Freres Gestion's LLY Position: Q2 2026 in Review

Wormser Freres Gestion reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $96K and leaving 560 shares worth $671K. The position accounts for 0.38% of the portfolio, ranked #24.

Wormser Freres Gestion first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $728K in Q4 2025. 1,233 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wormser Freres Gestion held 560 shares of Eli Lilly worth $671K as of Q2 2026.
  • Wormser Freres Gestion sold 94 Eli Lilly shares in Q2 2026, an estimated $96K.
  • Eli Lilly made up 0.38% of Wormser Freres Gestion's portfolio in Q2 2026, its #24 holding.
  • Wormser Freres Gestion first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Wormser Freres Gestion's Eli Lilly position peaked at $728K in Q4 2025.
  • 1,233 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wormser Freres Gestion's 13F filing for Q2 2026, filed 16 Jul 2026.